Received Dec 18, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
Covid; Covid; breathing problems; developed a cardiac condition; progression to a bifascicular block; This is a spontaneous report received from a Consumer or other non HCP from medical information team. A 79-year-old male patient received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "left anterior ventricular Fascicular" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Covid-19 vaccine, for COVID-19 Immunization; Fluvaccin, for Immunization. The following information was reported: BIFASCICULAR BLOCK (medically significant) with onset 2024, outcome "unknown", described as "progression to a bifascicular block"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Covid"; RESPIRATORY DISORDER (non-serious), outcome "unknown", described as "breathing problems"; CARDIAC DISORDER (non-serious), outcome "unknown", described as "developed a cardiac condition". No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.
Medical History/Concurrent Conditions: Left anterior fascicular block